Summit Therapeutics (SMMT) Priced

Developing novel therapies for muscular dystrophy and bacterial infections.

Health Care - Biotechnology

IPO Performance
Latest Trade $11.64 0.00 (0.0%)
First Day Return 2.9%
Return from IPO 17.6%
 
Summit Therapeutics IPO News more
  • .
IPO Data
IPO File Date 01/30/2015
Offer Price $9.90
Price Range $9.90 - $9.90
Offer Shares (mm) 3.5
Deal Size ($mm) 34
 
IPO Data
IPO Date 03/04/2015
Offer Price $9.90
Price Range $9.90 - $9.90
Offer Shares (mm) 3.5
Deal Size ($mm) $34
 
Underwriters
more
Business Overview
Developing novel therapies for muscular dystrophy and bacterial infections.
Developing novel therapies for muscular dystrophy and bacterial infections.
more
Company Data
Headquarters Abingdon, , United Kingdom
Founded 2003
Employees 23
Website www.summitplc.com
 

Performance vs. IPO Index (IPOUSA)